The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Galectin-3 Precipitates as a Pentamer with Synthetic Multivalent Carbohydrates and Forms Heterogeneous Cross-linked Complexes
Open accessAbstract
Galectin-3 is unique among the galectin family of animal lectins in its biological activities and structure. Most members of the galectin family including galectin-1 possess apoptotic activities, whereas galectin-3 possesses anti-apoptotic activity. Galectin-3 is also the only chimera type galectin and consists of a nonlectin N-terminal domain and a C-terminal carbohydrate-binding domain. Recent sedimentation equilibrium and velocity studies show that murine galectin-3 is a monomer in the absence and presence of LacNAc, a monovalent sugar. However, quantitative precipitation studies in the present report indicate that galectin-3 precipitates as a pentamer with a series of divalent pentasaccharides with terminal LacNAc residues. Furthermore, the kinetics of precipitation are fast, on the order of seconds. This indicates that although the majority of galectin-3 in solution is a monomer, a rapid equilibrium exists between the monomer and a small percentage of pentamer. The latter, in turn, precipitates with the divalent oligosaccharides, resulting in rapid conversion of monomer to pentamer by mass action equilibria. Mixed quantitative precipitation experiments and electron microscopy suggest that galectin-3 forms heterogenous, disorganized cross-linking complexes with the multivalent carbohydrates. This contrasts with galectin-1 and many plant lectins that form homogeneous, organized cross-linked complexes. The results are discussed in terms of the biological properties of galectin-3.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Colorimetric Method for Determination of Sugars and Related Substances
DuBois, M., Gilles, K. A., Hamilton, J. K., Rebers, P. A., & Smith, F. (1956) · Analytical Chemistry · doi:10.1021/ac60111a017 · Cited by 52,269
Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked
Yang, J., Liu, X., Bhalla, K., Kim, C. N., Ibrado, A. M., Cai, J., Peng, T.-I., Jones, D. P., & Wang, X. (1997) · Science · doi:10.1126/science.275.5303.1129 · Cited by 4,911
Galectins. Structure and function of a large family of animal lectins.
Barondes, S. H., Cooper, D. N., Gitt, M. A., & Leffler, H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31891-4 · Cited by 1,496
Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation
Demetriou, M., Granovsky, M., Quaggin, S., & Dennis, J. W. (2001) · Nature · doi:10.1038/35055582 · Cited by 901
Expression of galectin-3 modulates T-cell growth and apoptosis.
Yang, R. Y., Hsu, D. K., & Liu, F. T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.13.6737 · Cited by 789
Intracellular functions of galectins
Liu, F. (2002) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00313-6 · Cited by 675
Galectinomics: finding themes in complexity
Cooper, D. (2002) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(02)00310-0 · Cited by 585
Galectins: A Family of Animal Lectins That Decipher Glycocodes
Kasai, K.-I., & Hirabayashi, J. (1996) · Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021192 · Cited by 478
Galectin-3 Induces Endothelial Cell Morphogenesis and Angiogenesis
Nangia-Makker, P., Honjo, Y., Sarvis, R., Akahani, S., Hogan, V., Pienta, K. J., & Raz, A. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64959-0 · Cited by 446
Green, E. D., Adelt, G., Baenziger, J. U., Wilson, S., & Van Halbeek, H. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)81354-6 · Cited by 439
Cited by
TFOS DEWS II pathophysiology report
Bron, A. J., de Paiva, C. S., Chauhan, S. K., Bonini, S., Gabison, E. E., Jain, S., Knop, E., Markoulli, M., Ogawa, Y., Perez, V., et al. (2017) · The Ocular Surface · doi:10.1016/j.jtos.2017.05.011 · Cited by 1,815
Galectins as modulators of tumour progression
Liu, F.-T., & Rabinovich, G. A. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1527 · Cited by 1,439
Galectin-3: An open-ended story
Dumic, J., Dabelic, S., & Flögel, M. (2006) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2005.12.020 · Cited by 1,169
IgE in allergy and asthma today
Gould, H. J., & Sutton, B. J. (2008) · Nature Reviews Immunology · doi:10.1038/nri2273 · Cited by 1,136
Lau, K. S., Partridge, E. A., Grigorian, A., Silvescu, C. I., Reinhold, V. N., Demetriou, M., & Dennis, J. W. (2007) · Cell · doi:10.1016/j.cell.2007.01.049 · Cited by 914
“The steady-state distribution of glycoforms at the cell surface is calculated based on the binding avidities of glycoforms for galectin-3 (Ahmad et al., 2004), a prototypic galectin that is not limiting in this model.”
BackgroundRegulation of Cytokine Receptors by Golgi N-Glycan Processing and Endocytosis
Partridge, E. A., Le Roy, C., Di Guglielmo, G. M., Pawling, J., Cheung, P., Granovsky, M., Nabi, I. R., Wrana, J. L., & Dennis, J. W. (2004) · Science · doi:10.1126/science.1102109 · Cited by 735
Galectin-3 regulates myofibroblast activation and hepatic fibrosis
Henderson, N. C., Mackinnon, A. C., Farnworth, S. L., Poirier, F., Russo, F. P., Iredale, J. P., Haslett, C., Simpson, K. J., & Sethi, T. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511167103 · Cited by 625
Johannes, L., Jacob, R., & Leffler, H. (2018) · Journal of Cell Science · doi:10.1242/jcs.208884 · Cited by 618
The regulation of inflammation by galectin‐3
Henderson, N. C., & Sethi, T. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00794.x · Cited by 522
Galectin-3 and Galectin-1 Bind Distinct Cell Surface Glycoprotein Receptors to Induce T Cell Death
Stillman, B. N., Hsu, D. K., Pang, M., Brewer, C. F., Johnson, P., Liu, F.-T., & Baum, L. G. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.2.778 · Cited by 507
Self-citationMetabolism, Cell Surface Organization, and Disease
Dennis, J. W., Nabi, I. R., & Demetriou, M. (2009) · Cell · doi:10.1016/j.cell.2009.12.008 · Cited by 450
Stowell, S. R., Arthur, C. M., Mehta, P., Slanina, K. A., Blixt, O., Leffler, H., Smith, D. F., & Cummings, R. D. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709545200 · Cited by 418
Galectins: regulators of acute and chronic inflammation
Liu, F., & Rabinovich, G. A. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05131.x · Cited by 405
Functional roles of N‐glycans in cell signaling and cell adhesion in cancer
Zhao, Y., Takahashi, M., Gu, J., Miyoshi, E., Matsumoto, A., Kitazume, S., & Taniguchi, N. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00839.x · Cited by 405
N-Glycans in cancer progression
Lau, K. S., & Dennis, J. W. (2008) · Glycobiology · doi:10.1093/glycob/cwn071 · Cited by 390
“For example, the C-terminus of galectin-3 can form up to pentamers in the presence of multivalent ligands, generating a “lattice” microdomain with an irregular geometry (Ahmad et al. 2003).”
BackgroundFunctions of cell surface galectin-glycoprotein lattices
Rabinovich, G. A., Toscano, M. A., Jackson, S. S., & Vasta, G. R. (2007) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2007.09.002 · Cited by 389
Galectin-3, a marker for vacuole lysis by invasive pathogens
Paz, I., Sachse, M., Dupont, N., Mounier, J., Cederfur, C., Enninga, J., Leffler, H., Poirier, F., Prevost, M.-C., Lafont, F., et al. (2010) · Cellular Microbiology · doi:10.1111/j.1462-5822.2009.01415.x · Cited by 381
Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z
Sciacchitano, S., Lavra, L., Morgante, A., Ulivieri, A., Magi, F., De Francesco, G., Bellotti, C., Salehi, L., & Ricci, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020379 · Cited by 377
Galectin-3 – A jack-of-all-trades in cancer
Newlaczyl, A. U., & Yu, L.-G. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.09.003 · Cited by 362
Galectin-3 Mediates Aldosterone-Induced Vascular Fibrosis
Calvier, L., Miana, M., Reboul, P., Cachofeiro, V., Martinez-Martinez, E., de Boer, R. A., Poirier, F., Lacolley, P., Zannad, F., Rossignol, P., et al. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.300569 · Cited by 359
Lattices, rafts, and scaffolds: domain regulation of receptor signaling at the plasma membrane
Lajoie, P., Goetz, J. G., Dennis, J. W., & Nabi, I. R. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200811059 · Cited by 344
Glycosylation, galectins and cellular signaling
Boscher, C., Dennis, J. W., & Nabi, I. R. (2011) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2011.05.001 · Cited by 341
Cell surface biology mediated by low affinity multivalent protein–glycan interactions
Collins, B. E., & Paulson, J. C. (2004) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2004.10.004 · Cited by 335
Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response
Markowska, A. I., Liu, F.-T., & Panjwani, N. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20090121 · Cited by 330
The galectin lattice at a glance
Nabi, I. R., Shankar, J., & Dennis, J. W. (2015) · Journal of Cell Science · doi:10.1242/jcs.151159 · Cited by 329
Galectin-3 drives glycosphingolipid-dependent biogenesis of clathrin-independent carriers
Lakshminarayan, R., Wunder, C., Becken, U., Howes, M. T., Benzing, C., Arumugam, S., Sales, S., Ariotti, N., Chambon, V., Lamaze, C., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb2970 · Cited by 321
Percec, V., Leowanawat, P., Sun, H.-J., Kulikov, O., Nusbaum, C. D., Tran, T. M., Bertin, A., Wilson, D. A., Peterca, M., Zhang, S., et al. (2013) · Journal of the American Chemical Society · doi:10.1021/ja403323y · Cited by 310
Self-citationGalectin-3 Activation and Inhibition in Heart Failure and Cardiovascular Disease: An Update
Suthahar, N., Meijers, W. C., Silljé, H. H. W., Ho, J. E., Liu, F.-T., & de Boer, R. A. (2018) · Theranostics · doi:10.7150/thno.22196 · Cited by 309
Regulation of Transmembrane Signaling by Phase Separation
Case, L. B., Ditlev, J. A., & Rosen, M. K. (2019) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-052118-115534 · Cited by 303
Yu, L.-G., Andrews, N., Zhao, Q., McKean, D., Williams, J. F., Connor, L. J., Gerasimenko, O. V., Hilkens, J., Hirabayashi, J., Kasai, K., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m606862200 · Cited by 303
Sweetening the Pot: Adding Glycosylation to the Biomarker Discovery Equation
Drake, P. M., Cho, W., Li, B., Prakobphol, A., Johansen, E., Anderson, N. L., Regnier, F. E., Gibson, B. W., & Fisher, S. J. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2009.136333 · Cited by 302
Sato, S., St‐Pierre, C., Bhaumik, P., & Nieminen, J. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00790.x · Cited by 299
Hematopoietic-Derived Galectin-3 Causes Cellular and Systemic Insulin Resistance
Li, P., Liu, S., Lu, M., Bandyopadhyay, G., Oh, D., Imamura, T., Johnson, A. M. F., Sears, D., Shen, Z., Cui, B., et al. (2016) · Cell · doi:10.1016/j.cell.2016.10.025 · Cited by 297
When Galectins Recognize Glycans: From Biochemistry to Physiology and Back Again
Di Lella, S., Sundblad, V., Cerliani, J. P., Guardia, C. M., Estrin, D. A., Vasta, G. R., & Rabinovich, G. A. (2011) · Biochemistry · doi:10.1021/bi201121m · Cited by 282
Galectin expression in cancer diagnosis and prognosis: A systematic review
Thijssen, V. L., Heusschen, R., Caers, J., & Griffioen, A. W. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.03.003 · Cited by 279
Liu, Y.-H., D'Ambrosio, M., Liao, T.-D., Peng, H., Rhaleb, N.-E., Sharma, U., André, S., Gabius, H.-J., & Carretero, O. A. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00747.2008 · Cited by 269
Self-citationLectins as pattern recognition molecules: The effects of epitope density in innate immunity
Dam, T. K., & Brewer, C. F. (2010) · Glycobiology · doi:10.1093/glycob/cwp186 · Cited by 257
Self-citationArgüeso, P., Guzman-Aranguez, A., Mantelli, F., Cao, Z., Ricciuto, J., & Panjwani, N. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.033332 · Cited by 257
Stowell, S. R., Qian, Y., Karmakar, S., Koyama, N. S., Dias-Baruffi, M., Leffler, H., McEver, R. P., & Cummings, R. D. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.5.3091 · Cited by 255
Plasma membrane domain organization regulates EGFR signaling in tumor cells
Lajoie, P., Partridge, E. A., Guay, G., Goetz, J. G., Pawling, J., Lagana, A., Joshi, B., Dennis, J. W., & Nabi, I. R. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200611106 · Cited by 253
Adaptive Regulation at the Cell Surface by N ‐Glycosylation
Dennis, J. W., Lau, K. S., Demetriou, M., & Nabi, I. R. (2009) · Traffic · doi:10.1111/j.1600-0854.2009.00981.x · Cited by 219
“glycoproteins with multiple N-glycans) (13).”
BackgroundThe therapeutic potential of galectin-3 inhibition in fibrotic disease
Slack, R. J., Mills, R., & Mackinnon, A. C. (2021) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2020.105881 · Cited by 136
Nagasaki, A., Sakamoto, S., Chea, C., Ishida, E., Furusho, H., Fujii, M., Takata, T., & Miyauchi, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-60904-8 · Cited by 82
Roy, R., Murphy, P., & Gabius, H.-J. (2016) · Molecules · doi:10.3390/molecules21050629 · Cited by 76
Self-citationGalectin-3-Mediated Glial Crosstalk Drives Oligodendrocyte Differentiation and (Re)myelination
Thomas, L., & Pasquini, L. A. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00297 · Cited by 76
IgE immunotherapy: A novel concept with promise for the treatment of cancer
Josephs, D. H., Spicer, J. F., Karagiannis, P., Gould, H. J., & Karagiannis, S. N. (2014) · mAbs · doi:10.4161/mabs.27029 · Cited by 58
Murphy, P., André, S., & Gabius, H.-J. (2013) · Molecules · doi:10.3390/molecules18044026 · Cited by 54
Self-citationShafaq-Zadah, M., Dransart, E., Hamitouche, I., Wunder, C., Chambon, V., Valades-Cruz, C. A., Leconte, L., Sarangi, N. K., Robinson, J., Bai, S.-K., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-64523-7 · Cited by 12
“However, the shapes and assembly mechanisms of Gal3 oligomers remained controversial 54,55 .”
Role of Galectins in Metastatic Breast Cancer
Grazier, J. J., & Sylvester, P. W. (2022) · Breast Cancer · doi:10.36255/exon-publications-breast-cancer-galectins · Cited by 5
Metadata
- Authors
- Ahmad, N., Gabius, H.-J., André, S., Kaltner, H., Sabesan, S., Roy, R., Liu, B., Macaluso, F., & Brewer, C. F.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-03
- Volume
- 279
- Issue
- 12
- Pages
- 10841-10847
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2157903759
- Cited by
- 517
- References
- 44
- FWCI
- 7.12
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.